Loading…
OptimizeRx Corporation is projected to rise to $7.35 by 2027, a +15% move from its current price of $6.41. OPRX is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $6.21 | $6.41 | $6.62 | +0.04% |
| Jul 14 | $6.13 | $6.41 | $6.71 | +0.07% |
| Jul 15 | $6.08 | $6.42 | $6.78 | +0.11% |
| Jul 16 | $6.03 | $6.42 | $6.84 | +0.14% |
| Jul 17 | $5.98 | $6.42 | $6.89 | +0.18% |
| Jul 18 | $5.95 | $6.42 | $6.94 | +0.21% |
| Jul 19 | $5.91 | $6.43 | $6.99 | +0.25% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $5.91 | $6.43 | $6.99 | +0.25% |
| Week 2 | $5.72 | $6.44 | $7.25 | +0.50% |
| Week 3 | $5.59 | $6.46 | $7.46 | +0.75% |
| Week 4 | $5.48 | $6.47 | $7.65 | +1.00% |
| Week 5 | $5.39 | $6.49 | $7.82 | +1.25% |
| Week 6 | $5.30 | $6.51 | $7.98 | +1.50% |
| Week 7 | $5.23 | $6.52 | $8.13 | +1.75% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
OptimizeRx Corporation operates as a digital healthcare technology company. It offers a Dynamic Audience Activation Platform, which generates dynamic audiences with predictive analytics through machine learning methods; Micro-Neighborhood Targeting, which creates consumer audiences using a privacy-first process; Profiler, which provides insights into its customers' target consumers; banner messages, including brand messaging, therapeutic support messaging, affordability messaging, limited distribution drug information, and patient support program messaging through healthcare professionals; and media execution solutions, which deliver messages through a consumer omnichannel network, including through programmatic display, programmatic connected television/over-the-top, programmatic social media, addressable television, digital out-of-home, programmatic audio, and email/direct mail. The company also offers pharmacy alerts, which flag pharmacies that have prescription medications in stock; and financial messaging solutions, which provide prescribers visibility to branded copay offers for patients directly within electronic health record systems and ePrescribing platforms.
The company was founded in 2006 and is headquartered in Waltham, Massachusetts.
OptimizeRx Corporation (OPRX) is a healthcare-focused technology company with a current price of $6.08. It holds a market cap of $114.09M and is ranked 4169 by market capitalization. The stock’s current price sits within a broad 30-day range and sits amid a bullish technical backdrop with notable volatility.
The forecasted path shows rising averages across the next years, culminating in a significantly higher price by 2050.
A major floor 38.9% below — a decisive break under it would weaken the trend.
The nearest floor, 29.2% below — buyers have tended to step in here.
Price is pressing into resistance (0.0% away) — a breakout level to watch.
A major ceiling 22.8% above — clearing it would confirm fresh momentum.
Key OPRX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of OPRX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $6.30 | Buy | $6.24 | Buy |
| MA 10 | $6.00 | Buy | $6.00 | Buy |
| MA 20 | $5.50 | Buy | $5.72 | Buy |
| MA 50 | $5.52 | Buy | $5.78 | Buy |
| MA 100 | $6.19 | Buy | $6.88 | Sell |
| MA 200 | $10.64 | Sell | $8.73 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 67.07 | Neutral |
| Stoch RSI (14) | 95.60 | Sell |
| CCI (20) | 111.01 | Buy |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | 0.15 | Buy |
| ROC (12) | 41.19 | Buy |
| Bollinger %B (20,2) | 0.87 | Neutral |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | 0.32 | Buy |
| Awesome (5,34) | 0.97 | Buy |
| Ultimate (7,14,28) | 77.44 | Sell |
| Momentum (10) | 1.51 | Buy |
| Aroon Osc (25) | 48.00 | Buy |
| Hull MA (9) | 6.38 | Buy |
| ADX (14) | 22.86 | Buy |
| ATR (14) | 0.17 | Info |
The 30-day technical picture is bullish overall, with RSI14 at 70 indicating strong momentum. The chart shows the price trading above the 50-day moving average, which sits at $5.55, while the 200-day moving average is at $11.00, highlighting a potential longer-term uptrend as momentum shifts.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $4.54 | $6.41 | $7.92 | 0% | Neutral | |
| $5.77 | $7.35 | $9.96 | +15% | Neutral | |
| $6.45 | $8.50 | $12.01 | +33% | Bullish | |
| $7.81 | $10.57 | $15.43 | +65% | Bullish | |
| $8.05 | $11.17 | $16.75 | +74% | Bullish | |
| $7.48 | $10.61 | $16.30 | +66% | Bullish | |
| $8.28 | $11.98 | $18.79 | +87% | Bullish | |
| $8.30 | $12.25 | $19.60 | +91% | Bullish | |
| $8.50 | $12.78 | $20.81 | +99% | Bullish | |
| $10.59 | $16.20 | $26.81 | +153% | Bullish | |
| $12.22 | $20.28 | $35.94 | +216% | Bullish | |
| $23.70 | $45.40 | $88.78 | +608% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $4.54 | $6.41 | $7.58 | +0.00% |
| August 2026 | $5.38 | $6.37 | $7.78 | -0.55% |
| September 2026 | $5.54 | $6.62 | $8.18 | +3.86% |
| October 2026 | $5.43 | $6.54 | $8.16 | -1.30% |
| November 2026 | $5.15 | $6.23 | $7.85 | -4.64% |
| December 2026 | $5.12 | $6.24 | $7.92 | +0.05% |
Click any year to see its month-by-month OPRX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, OPRX is projected to trade between $4.54 and $7.92, averaging $6.41 — a potential gain of 0% from today's $6.41. Price action looks broadly range-bound.
OptimizeRx Corporation's 2027 outlook centres on $7.35, within a $5.77 to $9.96 range. That is up +15% on the projected 2026 average. That marks a +15% change versus current levels. A consolidation phase looks the most probable path here.
By 2028, OPRX could reach as high as $12.01, with a base case around $8.50 and support toward $6.45 — roughly +33% from $6.41. Momentum favours further upside here.
Expect OPRX to range from $7.81 to $15.43 through 2029. The $10.57 average target implies a +65% move from current prices. That is up +24% on the projected 2028 average. Buyers look set to stay in control over this stretch.
The OPRX price prediction for 2030 points to an average of $11.17 (low $8.05, high $16.75) — a potential gain of +74% on today's $6.41. Momentum favours further upside here.
In 2031, OPRX is projected to trade between $7.48 and $16.30, averaging $10.61 — a potential gain of +66% from today's $6.41. That is -5% versus the projected 2030 average. Buyers look set to stay in control over this stretch.
OptimizeRx Corporation's 2032 outlook centres on $11.98, within a $8.28 to $18.79 range. That is up +13% on the projected 2031 average. That marks a +87% change versus current levels. Momentum favours further upside here.
By 2033, OPRX could reach as high as $19.60, with a base case around $12.25 and support toward $8.30 — roughly +91% from $6.41. Buyers look set to stay in control over this stretch.
Expect OPRX to range from $8.50 to $20.81 through 2034. The $12.78 average target implies a +99% move from current prices. That is up +4% on the projected 2033 average. Momentum favours further upside here.
The OPRX price prediction for 2035 points to an average of $16.20 (low $10.59, high $26.81) — a potential gain of +153% on today's $6.41. Buyers look set to stay in control over this stretch.
In 2040, OPRX is projected to trade between $12.22 and $35.94, averaging $20.28 — a potential gain of +216% from today's $6.41. That is up +25% on the projected 2035 average. Momentum favours further upside here.
OptimizeRx Corporation's 2050 outlook centres on $45.40, within a $23.70 to $88.78 range. That is up +124% on the projected 2040 average. That marks a +608% change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in OPRX today (≈ 156.00624 OPRX) could be worth
$7,083.18
+$6,083.18 (+608%) by 2050 · US Dollar
Based on the average projected OPRX price of $45.4 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in OPRXwould be worth at today's price.
$1,000 invested in OPRX on Jul 10, 2025 (≈ 75.301206 OPRX) would be worth
$482.68
-$517.32 (-51.7%) today · 0.48× · US Dollar
Based on a OPRX entry price of $13.28 vs. today's $6.41.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $6.19 | $1,035.54 | +3.6% |
| 1 month ago | $5.08 | $1,261.81 | +26.2% |
| 3 months ago | $6.13 | $1,045.68 | +4.6% |
| 6 months ago | $14.06 | $455.9 | -54.4% |
| 1 year ago | $13.28 | $482.68 | -51.7% |
| All time (5.0y) ago | $53.35 | $120.15 | -88.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our OPRX forecast.
Our base-case forecast reaches $13.00 around 2035.
Implied market cap at $13.00: $243.95M
Looking across the multi-year forecast, the asset shows meaningful upside potential. In 2030 the average price is $9.84 with a min of $6.88 and a max of $15.27, and ROI of 61.9. By 2040 the average price is projected at $16.10 with ROI of 164.8, and by 2050 the average price is $35.94 with ROI of 491.1.
Earlier years show positive momentum beginning in 2027 and intensifying through 2029, with 2029 averaging $9.60 and ROI 57.9. These are estimates, not guarantees, and carry inherent uncertainty and risk.
Tap a question to reveal the answer.
In 2030, the forecasted average price is $9.84 with a min of $6.88 and a max of $15.27, and ROI of 61.9.
The forecast indicates bullish momentum in later years with rising averages (e.g., 2030 avg $9.84, ROI 61.9; 2040 avg $16.10, ROI 164.8; 2050 avg $35.94, ROI 491.1), but these are estimates and not guarantees.
Yes—the max forecast for 2050 is $74.54, with an average of $35.94 and ROI 491.1.
The current price is $6.08.
Sentiment is BULLISH; RSI14 is 70. The SMA50 is $5.55 and the SMA200 is $11.00. Support is at $4.54 and resistance at $6.08, with a 30-day range of $4.79 to $7.72.
OptimizeRx Corporation Community Discussion
0Share your OptimizeRx Corporation price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.